Resultats de la cerca - Rahul Aggarwal

Refinar resultats
  1. 1
    Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients

    Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients per Rahul Aggarwal, Benjamin Petrie, Wasif Bala, Nicholas Chiu

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020

    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020 per Rahul Aggarwal, Robert W. Yeh, Karen E. Joynt Maddox, Rishi K. Wadhera

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018

    Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018 per Rahul Aggarwal, Deepak L. Bhatt, Fátima Rodríguez, Robert W. Yeh, Rishi K. Wadhera

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    The MELD-Plus: A generalizable prediction risk score in cirrhosis

    The MELD-Plus: A generalizable prediction risk score in cirrhosis per Uri Kartoun, Kathleen E. Corey, Tracey G. Simon, Hui Zheng, Rahul Aggarwal, Kenney Ng, Stanley Y. Shaw

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

    Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden per Victoria E. Wang, Anatoly Urisman, Lee A. Albacker, Siraj M. Ali, Vincent A. Miller, Rahul Aggarwal, David M. Jablons

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018

    Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018 per Rahul Aggarwal, Nicholas Chiu, Rishi K. Wadhera, Andrew E. Moran, Inbar Raber, Changyu Shen, Robert W. Yeh, Dhruv S. Kazi

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020

    Cardiovascular Health of Middle-Aged U.S. Adults by Income Level, 1999 to March 2020 per Michael Liu, Rahul Aggarwal, ZhaoNian Zheng, Robert W. Yeh, Dhruv S. Kazi, Karen E. Joynt Maddox, Rishi K. Wadhera

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis

    The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis per Ronald Chow, James Im, Nicholas Chiu, Leonard Chiu, Rahul Aggarwal, Jihui Lee, Young‐Geun Choi, Elizabeth Horn Prsic, Hyun Joon Shin

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Pre- or post-chemotherapy: effect on PSMA uptake

    Pre- or post-chemotherapy: effect on PSMA uptake per Surekha Yadav, Abuzar Moradi Tuchayi, Moein Moradpour, Fei Jiang, Roxanna Juarez, Ivan de Kouchkovsky, Robert R. Flavell, Rahul Aggarwal, Thomas A. Hope

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Systemic nature of spinal muscular atrophy revealed by studying insurance claims

    Systemic nature of spinal muscular atrophy revealed by studying insurance claims per Scott Lipnick, Denis Agniel, Rahul Aggarwal, Nina R. Makhortova, Samuel G. Finlayson, Alexandra Brocato, Nathan Palmer, Basil T. Darras, Isaac S. Kohane, Lee L. Rubin

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    <sup>68</sup>Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience

    <sup>68</sup>Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience per Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar‐Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small, Michael J. Evans

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms

    DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms per James C. Yao, Emily K. Bergsland, Rahul Aggarwal, Ana M. Aparicio, Himisha Beltran, Judy S. Crabtree, Christine L. Hann, Toni Ibrahim, Lauren A. Byers, Hironobu Sasano, John Umejiego, Marianne Pavel

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer

    Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer per Thomas A. Hope, Rahul Aggarwal, Bryant H. Chee, Dora Tao, Kirsten L. Greene, Matthew R. Cooperberg, Felix Feng, Albert J. Chang, Charles J. Ryan, Eric J. Small, Peter R. Carroll

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer

    Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer per Emerson A. Lim, Michael T. Schweizer, Kim N., Rahul Aggarwal, Neeraj Agarwal, James L. Gulley, Edward F. Attiyeh, James Greger, Shujian Wu, Pharavee Jaiprasart, John T. Loffredo, Nibedita Bandyopadhyay, Hong Xie, Aaron R. Hansen

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer

    Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer per Vadim S. Koshkin, Vipul Kumar, Brad Kline, Domenique Escobar, Maya Aslam, Matthew R. Cooperberg, Rahul Aggarwal, Ivan de Kouchkovsky, Jonathan Chou, Maxwell V. Meng, Terence W. Friedlander, Sima P. Porten, Thomas A. Hope

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies

    Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies per Rahul Aggarwal, Scott Thomas, Nela Pawłowska, Imke H. Bartelink, Jennifer A. Grabowsky, Thierry Jahan, Amy Cripps, Armand Harb, Jim Leng, Anne Reinert, Ilaria Mastroserio, Thach-Giao Truong, Charles J. Ryan, Pamela N. Münster

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Potential global impact of <scp>sodium–glucose</scp> cotransporter‐2 inhibitors in heart failure

    Potential global impact of <scp>sodium–glucose</scp> cotransporter‐2 inhibitors in heart failure per Khawaja M. Talha, Javed Butler, Stephen J. Greene, Rahul Aggarwal, Stefan D. Anker, Brian Claggett, Kieran F. Docherty, Scott D. Solomon, John J.V. McMurray, James L. Januzzi, Muthiah Vaduganathan, Gregg C. Fonarow

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants

    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants per Rahul Aggarwal, Christian T. Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric A. Secemsky, Jonathan P. Piccini, Usman A. Tahir, Changyu Shen, Robert W. Yeh

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial

    Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial per Rahul Aggarwal, Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller, Eliot A. Brinton, Richard L. Dunbar, Steven B. Ketchum, Jean‐Claude Tardif, F M A C Martens, Christie M. Ballantyne, Michael Szarek, R. Preston Mason

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

    Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer per Janice M. Mehnert, Andréa Varga, Marcia S. Brose, Rahul Aggarwal, Chia‐Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A. Piha‐Paul, Jill Gilbert, Sanatan Saraf, Pradeep Thanigaimani, Jonathan D. Cheng, Bhumsuk Keam

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: